Node; Prostate
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736) (NCT03795207) | Institut Cancerologie de l'Ouest | 2019-03-21 |
Track Node; Prostate automatically
Every clearance here is in the API, with alerts when new ones post.